Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma - van der Ree, M H; van der Meer, A J; van Nuenen, A C (Aliment Pharmacol Ther, 2016)
, et al.